# Stem Cell Transplant w/Laronidase for Hurler

> **NCT00176891** · PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 25 (actual)

## Conditions studied

- Mucopolysaccharidosis I
- Hurler Syndrome

## Interventions

- **PROCEDURE:** Stem Cell Transplant
- **DRUG:** Laronidase ERT

## Key facts

- **NCT ID:** NCT00176891
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176891, "Stem Cell Transplant w/Laronidase for Hurler". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00176891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*